Generatixe, Inc.
Generatixe delivers AI-assisted bioengineering to accelerate antibody, nanobody, mRNA, and gene therapy development. It uses a Bioinformed AI approach that leverages real-world biodata from verified lab experiments to minimize computational work while improving accuracy. The company applies core generative models and vector design for in vivo delivery of proteins, RNA, and DNA to enable advanced biotherapeutics. Its platform integrates with lab data workflows and serves biotech and pharmaceutical teams seeking faster, more reliable discovery and development. The market focus is on biomedicine where AI-bio collaboration scales research capabilities and therapeutic outcomes.
Generatixe, Inc.
Generatixe delivers AI-assisted bioengineering to accelerate antibody, nanobody, mRNA, and gene therapy development. It uses a Bioinformed AI approach that leverages real-world biodata from verified lab experiments to minimize computational work while improving accuracy. The company applies core generative models and vector design for in vivo delivery of proteins, RNA, and DNA to enable advanced biotherapeutics. Its platform integrates with lab data workflows and serves biotech and pharmaceutical teams seeking faster, more reliable discovery and development. The market focus is on biomedicine where AI-bio collaboration scales research capabilities and therapeutic outcomes.